medicalxpress - The proportion of extensively drug-resistant (XDR) Shigella isolates in the United States increased from 2011–2015 to 2023, according to research published in the April 9 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality…
AI Summary: Federal health officials report a worrying uptick in extensively drug‑resistant Shigella strains, complicating treatment and raising the risk of harder‑to‑control outbreaks. The data underscore the need for enhanced surveillance, hygiene measures, antibiotic stewardship and rapid public‑health responses as standard antibiotics lose reliability. Try not to spread it—literally.
Senate confirms Dr. Erica Schwartz as CDC director / 21 days
Spike in parasitic diarrhea outbreak hits Michigan and other states / 7 wks
Warming waters fuel surge in flesh‑eating bacterial infections; officials warn / 17 days
Congo Ebola outbreak intensifies as response faces attacks and quarantines / 5 wks
HHS and CDC overhaul vaccine advisory panels after judge ruling / 4 months
Measles resurgence raises risk of rare fatal neurological complication / 5 months
RFK appoints two new members to CDC vaccine advisory panel ahead of meeting / 5 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.